Introduction
Many hematological diseases, such as thalassemia major, sickle cell disease and aplastic anemia, require life-long transfusion support. Currently, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only available curative treatment for these diseases. [1] [2] [3] However, these patients are at a relatively high risk of graft rejection compared to leukemic patients after allo-HSCT. 4, 5 Given that these patients received repeated transfusions from HLA-mismatched donors before transplantation, they would be sensitized easily and produce high levels of donor-reactive antibodies. These donor-reactive antibodies have been found in patients with aplastic anemia several decades ago and also been found in patients with sickle cell disease and thalassemia recently. [6] [7] [8] It has been recently reported that the high levels of donor-reactive antibodies associated with repeated transfusions is due to the white blood cells present in allogeneic blood products. 8 Besides transfusions, other challenges such as pregnancies, prior transplantation and the use of ventricular assist devices are also associated with the production of donorreactive antibodies. 9 In solid organ transplantation, these antibodies have been found to be correlated with graft rejection. [10] [11] [12] Although the exact mechanism is unclear, it has been suggested that the donor-reactive antibodies may impair the graft through both complement-dependent and complement-independent pathways. 13 Allo-HSCT is different from solid organ transplantation because the donor graft cells present in the blood have direct contact with recipient immune cells in the circulation to activate donorreactive antibody production. 14 The effect of these antibodies on the hematopoietic stem cells and their role in hematopoietic engraftment are worthy of investigation. Prior studies on this subject have been conducted several decades ago, but the results were controversial. [15] [16] [17] Recently, using a sensitized murine model, Xu et al. 14 demonstrated that donor-reactive antibodies play a 0primary role in the rejection of allogeneic marrow, while T cell-mediated immunity plays a secondary role. Although they demonstrated marrow graft rejection in sensitized mice, the mechanism of the engraftment and homing of donor bone marrow cells (BMCs) was not explored. Here, we established a fully major histocompatibility complexdisparate HSCT model between C57BL/6 and sensitized BALB/c mice to investigate the mechanism of engraftment and homing impairment of donor hematopoietic stem cell graft in a highly sensitized recipient. Male C57BL/6 (H-2K b ) and BALB/c (H-2K d ) mice, aged 6-8 weeks, and weighing 18-20 g, were purchased from the Experimental Animal Center of Zhongshan University (Guangzhou, China). All mice were maintained under pathogen-free conditions at our facility.
Materials and methods

Animals
Sensitized animal model BALB/c mice were sensitized by repeated transfusions of allogeneic spleen cells from C57BL/6 mice. Briefly, C57BL/ 6 mice were killed, and their spleens were removed and teased into single-cell suspensions. After centrifugation at 1000 r.p.m. for 5 min, the cell pellet was harvested and resuspended in 2 ml of lysing buffer (8.29 g of NH 4 Cl, 1.0 g of KHCO 3 and 0.0372 g of Na 2 EDTA in 1 l water) to eliminate red blood cells. A total of 1 Â 10 6 nucleated leukocytes (0.1 ml) were transfused to BALB/c mice via their tail vein weekly for 2 weeks (on day À14 and day À7, respectively), and ready to be used as a sensitized model by the third week.
Bone marrow transplantation
The recipient BALB/c mice were maintained on acidified water with added antibiotics (cidomycin, 32 Â 10 4 U/l and erythromycin, 250 mg/l) 5 days before transplantation. Both sensitized and non-sensitized mice underwent total body irradiation with 800 cGy using cobalt-60 g-rays.
A total of 1 Â 10 7 (0.2 ml) of BMCs, obtained from femurs and tibias of donor C57BL/6 mice, were labeled with the cell tracker, 5-and 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) and then injected into the recipients. Normal BALB/c mice without any treatment, or only receiving irradiation alone were used as control groups.
Donor-reactive antibodies
The presence of donor-reactive antibodies was tested using the complement-dependent cytotoxicity (CDC) method. Briefly, serum of recipient mice was collected after irradiation, and donor C57BL/6 splenocytes were resuspended at 2 Â 10 7 cells/ml in RPMI-1640 medium. Ten microliters each of serum samples and splenocytes were added in 96-well culture plates. Wells were washed once after incubation at 371C for 30 min. Ten microliters of rabbit complement (One Lambda Company Limited, Canoga Park, CA, USA) was added and incubated for another 30 min. The fluorescent dye ethidium bromide/ acridine orange (EB/AO) was added and the percent of non-viable cells was determined by manual counting using a fluorescence microscope. C57BL/6 splenocytes incubated with RPMI-1640 medium or serum alone, as well as splenocytes incubated with complement alone were used as control groups. The intensity of reaction was evaluated as follows: less than 10% dead cells was considered as negative, the range of 10-20% as doubtful positive, 20-40% as weakly positive and 40-80% as positive. 18 Survival and death analysis Sensitized and non-sensitized mice that underwent lethal irradiation followed by allogeneic or non-allogeneic bone marrow transplantation were analyzed for survival percentages. Mortality was scored daily. The survival rate was determined 28 days post-transplantation. The causes of death were analyzed by peripheral blood cell counts and BMCs per femur, as well as by histological sections of lung, liver, small intestine, skin and femur of dying animals.
Engraftment assay
Peripheral blood counts. Twenty microliters of peripheral blood collected in 1-ml tube with buffer was obtained from the tails of recipients every week after transplantation. Cell numbers were measured by a System KX-21 Hematology Series Cell Counter (Sysmex Company, Kobe, Japan).
BMCs counts. BMCs were obtained from femurs of the recipients every week after transplantation, and counted by using an inverted microscope. The remaining BMCs were used for the culture of colonies and the chimerism analysis.
Colony-forming units for granulocyte/monocyte. Colonyforming units for granulocyte/monocyte (CFU-GM) colonies were assayed in methylcellulose medium (Methocult GFM3434; StemCell Technologies Inc., Vancouver, Canada). Briefly, BMCs were suspended in RPMI-1640 medium at a concentration of 2 Â 10 5 cells/ml. A total of 2 Â 10 4 BMCs (0.1 ml) and methylcellulose medium (1 ml) were added to 35-mm dishes and incubated at 371C under 5% CO 2 in a humidified atmosphere. Colonies were counted under an inverted microscope ( Â 100) after 7 days of incubation. Clusters of 40 or more cells were scored as colonies.
H-2D
b chimeras. BMCs were suspended in RPMI-1640 medium and FITC-labeled H-2D b (BD PharMingen, San Diego, CA, USA) was added to the cells. After incubation on ice for 20 min, red blood cells were lysed and removed by washing. The cells were set aside for flow cytometric analysis (Becton Dickinson, San Jose, CA, USA).
Homing trace
BMCs labeled with CFSE. Before transplantation, donor BMCs were labeled with fluorescent dye CFSE (Invitrogen, Carlsbad, CA, USA). Briefly, donor BMCs were resuspended in phosphate-buffered saline (PBS) after hemolysis and washing. CFSE was then added to the cell suspensions at a final concentration of 10 mmol/l. After 10 min at 371C, further dye uptake was prevented by incubating cells with five times the volume of complete medium at À201C for 5 min. Then, the cells were washed three times in PBS, and resuspended in RPMI-1640 medium at a concentration of 5 Â 10 7 for future transplantation.
Frozen sections and blood smears. Sensitized and nonsensitized recipients were killed at specific time points (2, 12 and 48 h) post-transplantation. Frozen sections (5 mm) were made for spleen, liver, lung and femur; peripheral blood smears were obtained from retro-orbital sinus and analyzed under a fluorescence microscope. The fluorescent events were determined by the intensity per high-powered (HP, Â 100) field.
Cell suspensions and peripheral blood analysis. At the time points indicated above, cell suspensions collected from the femur and spleen, and retroorbital sinus undergo red cell depletion by treatment with lysing buffer and labeled with CFSE. The percentage of donor cells homing to the respective organ was determined by monitoring CFSE þ cells using flow cytometry.
Cytotoxic assay CDC test. Target BMCs from C57BL/6 were prepared at 2 Â 10 7 cells/ml in RPMI-1640 medium, and test sera were collected from non-sensitized BALB/c or sensitized model. Target cells (10 ml) and test serum samples (10 ml) were added in 96-well culture plates. After 30 min of incubation at 37 o C, wells were washed once and 10 ml per well of rabbit complement was added. After an additional 30 min of incubation at 371C, fluorescent dye EB/AO was added, and the percent of dead cells was scored 3 min later. Cytotoxic index was calculated as following:
Cytotoxic T-lymphocytes test. The test was performed as described by Marcusson-Stahl et al. 19 Briefly, splenocytes from non-sensitized BALB/c or sensitized model were used as effector cells. A total of 1 Â 10 6 (0.1 ml) target BMCs from C57BL/6, pulsed with CFSE, cultured with 1 Â 10 6 (0.1 ml) effector cells for 24 h at 37 o C and finally stained with PE-PI (Bender, MEDSYSTEMS, Burlingame, CA, USA). Determination of cytolysis is based on the enumeration of dead target cells (CFSE(hi)PI( þ )) in the test sample. Percent specific target cell death (cytotoxic index) was expressed as: ([% dead targets in the sampleÀ% spontaneously dead targets]/[100%À% spontaneously dead targets]) Â 100 ¼ cytotoxic index.
Antibody-dependent cellular cytotoxicity test. A total of 1 Â 10 6 (0.1 ml) target BMCs from C57BL/6, pulsed with CFSE, preincubated with 50 ml serum sample for 30 min at 371C washed three times, then cultured with 1 Â 10 6 (0.1 ml) effector cells for 24 h at 371C and finally stained with PE-PI. Determination of cytolysis is based on the enumeration of dead target cells (CFSE(hi)PI( þ )) in the test sample. The cytotoxic index was also expressed as: ([% dead targets in the sampleÀ% spontaneously dead targets]/[100%À% spontaneously dead targets]) Â 100 ¼ cytotoxic index.
Statistical analysis
Results are expressed as mean7s.e.m., and the data were analyzed by SPSS 11.0 statistical software (SPSS, China). Comparisons between experimental results were made using one-way analysis of variance test analysis. Values of log-rank P were determined using the Kaplan-Meier method comparing survival curves. A P-value of less than 0.05 was considered statistically significant.
Results
Sensitized sera have a higher level of donor-reactive antibodies compared to non-sensitized sera Sensitization was induced by repeated transfusions of allogeneic spleen cells from C57BL/6 to BALB/c recipients. Serum was collected from normal mice and sensitized mice after lethal irradiation. The level of donor-reactive antibodies was evaluated by the CDC method, which represents the intensity of the complement killing reaction. As shown in Table 1 , following 30 min of incubation with rabbit complement, sensitized serum in group D has a significantly increased intensity of reaction (% dead cells 4 40%), indicating high level of donor-reactive antibodies in the sensitized serum. In contrast, the reaction remained negative for serum from non-sensitized normal mice in group C and samples contain no serum in group B (% dead cells o10%). As expected, without addition of rabbit complement, there is no increased intensity of reaction in non-sensitized serum (group E) and in sensitized serum (group A).
Transplantation failures in sensitized recipients after irradiation
To test the survival duration of sensitized and nonsensitized mice after transplantation, the mice were irradiated with 800 cGy by using cobalt-60 g-rays. Without transplantation, the mice died at 10-16 days after irradiation, with a median of 14 days (Figure 1 ). The nonsensitized recipients, transplanted with 1 Â 10 7 of allogeneic BMCs from C57BL/6 mice, were alive 28 days after the irradiation. In contrast, sensitized recipients, receiving the same dose of BMCs, died at 12-15 days after irradiation, with a median of 13 days. By log-rank analysis there was a significant difference between the non-sensitized recipient group and the sensitized recipient group (Po0.0001), while there was no significant difference between the irradiated control group without transplantation and the sensitized recipient group (P40.05). These results demonstrated that the transplantation of BMCs could rescue non-sensitized recipients but not sensitized recipients.
To analyze the causes of death, peripheral blood and BMCs counts were determined for the dying transplantation recipients. In addition to becoming pancytopenic, BMCs number in the dying mice was also reduced when compared with normal BALB/c mice (data not shown). Moreover, the histologic analysis of bone marrow also demonstrated bone marrow failure (Figure 2 ). Large Table 1 Intensity of reaction in CDC tests numbers of red blood cells were observed in the histological sections of lung, liver, small intestine and skin, indicating that these mice died from internal hemorrhage. No apparent lymphocyte infiltration was observed in the tissues stated above, demonstrating that graft-versus-host disease phenomenon was not observed in these dying recipients (data not shown).
Engraftment capacity is impaired in sensitized recipients
Lethal irradiated BALB/c mice were infused with BMCs from C57BL/6 mice, and hematopoietic recovery was monitored weekly post-transplantation (Figures 3a-c) .
The results showed that white blood cells, hemoglobin and platelet count increased over time in non-sensitized recipients and reached normal levels on day 28 (P40.05). However, hematopoietic recovery was noted to be decreased with time in sensitized recipients. Comparing with these two groups, there were statistically significant differences in white blood cell and platelet counts on day 7 (Po0.05), and significant differences were found in white blood cell, platelet and hemoglobin counts on day 14 (Po0.001). Correlating to peripheral hematopoietic recovery, the number of BMCs per femur increased with time in non-sensitized recipients and decreased with time in sensitized recipients (Figure 3d ). There were also significant differences between these two groups on day 7 and day 14 post-transplantation (Po0.001). In addition, these data in the sensitized recipient group were paralleled with those in irradiated control group, and no significant differences were found between these two groups (P40.05).
The number of CFU-GM colonies is a measurement of progenitor cell recovery in marrow. No CFU-GM colonies could be found in BMCs of sensitized recipients obtained on day 7 or on day 14 post-transplantation. In contrast, the numbers of CFU-GM colonies in non-sensitized recipients were (53.675.94) on day 7 post-transplantation (Figure 3e ). The colony numbers increased with time in non-sensitized recipients and no significant difference was found on day 28 in comparison with BALB/c mice without irradiation treatment (data not shown).
To assess engraftment potential, donor cell chimerism was detected using FITC-conjugated anti-H-2D 
Sensitization reduces homing trace in different tissues of recipients
To perform the homing studies, allogeneic donor BMCs labeled with fluorescent dye CFSE were injected into sensitized and non-sensitized mice after lethal irradiation. The homing of BMCs to different tissues was evaluated using frozen sections and cell suspensions obtained from transplanted mice at specific time points (2, 12 and 48 h). Figure 1 Transplantation fails to rescue sensitized recipients after lethal irradiation. The irradiation control group was treated with lethal irradiation of 800 cGy from cobalt-60 g-rays, but without bone marrow transplantation; the sensitized recipient group or non-sensitized recipient group were transplanted with 1 Â 10 7 (0.2 ml) BMCs from C57BL/6 mice 4 h after the irradiation. Each group contained 10 BALB/c mice, and the survival events were monitored daily. Values of log-rank P were determined using the Kaplan-Meier method comparing survival curves performed with SPSS 11.0. BMC, bone marrow cells.
The fluorescent events of frozen sections and blood smears were analyzed under a fluorescence microscope. Comparing with non-sensitized recipients, no significant difference of fluorescent signals was found in the liver and lung of sensitized recipients at all time points (Table 2) flow cytometry. Two hours after BMC infusion, the percentage of donor CFSE þ cells in the peripheral blood of sensitized recipient group was threefold (Po0.001) less than the non-sensitized recipient group (Figure 4a ). No significant difference was found in the bone marrow and spleen between these two groups (P40.05). However, 12 h after BMCs infusion, the percentage of CFSE þ cells in the peripheral blood, bone marrow and spleen of the sensitized recipient group were significantly less than the nonsensitized group by 7.2-fold (Po0.001), 1.05-fold (Po0.05), 2.97-fold (Po0.001), respectively (Figure 4b ). Remarkably, 48 h after BMCs infusion, the difference of CFSE þ cells in the peripheral blood, bone marrow and spleen between sensitized and non-sensitized recipient group differed more greatly by 33-, 3.04-and 27.32-fold, respectively (Po0.001) (Figure 4c ).
Sensitization cause high cytotoxicity to donor BMCs
Cytotoxicity of the donor graft was evaluated by CDC, cytotoxic T-lymphocytes (CTL) and antibody-dependent cellular cytotoxicity (ADCC) tests ( Figure 5 ). Both the donor splenocytes and BMCs could be killed by sensitization through CDC pathway. The cytotoxic index of CDC test for non-sensitized samples and sensitized samples were (1.9370.25) and (44.6373.14)%, respectively, and the differences were statistically significant (Po0.001). Target donor BMCs in the CTL and ADCC tests were labeled with CFSE and PI, and the dead target cells were recognized as CFSE(hi)PI( þ ) cells. The cytotoxic index of CTL test for sensitized samples and non-sensitized samples were (44.2673.64) and (26.2473.03)%, respectively, and there were statistically significant differences between these two groups (Po0.001). Using ADCC test, the cytotoxicity of donor graft in sensitized group were much higher than those in non-sensitized sample group, (14.4572.16) vs (1.5870.28)%, respectively, and the differences were statistically significant (Po0.05).
Discussion
Our data demonstrated that we had successfully established a highly sensitized murine model, in which a high level of donor-reactive antibodies could be induced by repeated transfusions of allogeneic donor spleen cells. Other sensitized murine models using allogeneic skin grafting, 14, 20 intraperitoneal splenocytes administration 21 and platelet transfusion have been reported. 22 However, our model is representative of highly sensitized patients from repeated transfusions. It has been reported that transfusion of large doses of allogeneic spleen cells may cause immunosuppression in recipients, 23 while repeated transfusions of appropriate dose result in recipient sensitization. 22 Our results failed to show suppression of the immune system in this sensitized model (data not shown). BMCs from C57BL/6 were used as target cells, and splenocytes from nonsensitized BALB/c or sensitized model were used as effector cells. In our present study, a highly sensitized murine model was used for bone marrow transplantation. Our sensitized transplantation model revealed shortened survival for sensitized mice due to impaired homing and poor donor graft survival. The survival curves showed that all the sensitized mice died between 12-15 days post-transplantation, indicating that the injection of 1 Â 10 7 allogeneic BMCs could not rescue the sensitized mice from lethal irradiation (Figure 1 ). All death for sensitized mice after transplantation were due to bone marrow failure, pancytopenia and internal hemorrhage (Figure 2 ). The loss of donor graft in sensitized recipients was demonstrated by the lack of hematopoietic recovery, lack of hematopoietic progenitor cell (CFU-GM colonies) presence in the recipient bone marrow and decreased donor chimerism (Figure 3 ). Taken together, these evidences demonstrated that donor marrow graft was totally rejected by the highly sensitized recipients.
Hematopoietic stem cell homing is a fairly rapid process, measured in hours and taking no longer than 1-2 days. 24 Our experiment showed that after labeling with CFSE in vitro, the intensity of fluorescence for BMCs did not attenuate 48 h later (data not given). In both sensitized and non-sensitized recipients, migration of donor cells toward non-hematopoietic tissues peaked temporarily 2 h after BMCs infusion (Table 2) . Remarkably, the number of donor cells increased in the femur and spleen of nonsensitized recipients after 12 h, indicating that these were the main lodges for donor BMCs (Figure 4) . However, comparing with non-sensitized recipients, the rapid decrease of donor cell with time in the spleen and peripheral blood of sensitized recipients suggested that donor BMCs were destroyed in organs with enriched immune surveillance. In addition, similar results were found in the femur of sensitized recipients, this further confirmed that bone marrow environment is capable of eliciting memory immune responses to eliminate sensitized donor cells similar to hematopoietic and lymphoid organs. 25 The mechanism of marrow graft rejection in sensitized recipients has not been clearly defined. We evaluated the cytotoxicity of sensitization against donor BMCs by CDC, CTL and ADCC tests, and found that the cytotoxic index for sensitized samples were much higher than that for nonsensitized samples ( Figure 5 ). This implied that donor graft destruction might be linked to recipient-mediated graftspecific cell cytotoxicity, which was induced by prior exposure of donor cells. Our data have shown that the mechanism of cell cytotoxicity might be via the CDC, CTL and ADCC pathways. These results agreed with the findings of other studies. Taylor et al. 21 found that donor BMCs incubate with serum from primed mice were eliminated in non-primed recipients, and the rejection was dependent upon host FcR þ cells. These data indicated that the ADCC pathway played an important role in sensitized recipients; in addition to humoral immunity, memory T cells from sensitized recipients could also be responsible for BMCs rejection. 26 In conclusion, our research has established a highly sensitized murine model by repeated transfusions of allogeneic donor spleen cells. Simultaneously, we have found that both the engraftment and homing capacity of hematopoietic stem cells may be impaired in sensitized recipients. In addition, host sensitization can induce donor BMCs cytotoxicity through CDC, CTL and ADCC pathways. Our model is representative of marrow graft rejection in highly sensitized allo-HSCT patients, and our finding may contribute to the understanding of graft rejection in this patient population.
